TableĀ 2

Clinical characteristics of whole cohort (4907 patients) and in patients with and without AF (740 and 4167 patients, respectively)

Whole cohortSRAF
Variablenmean (SD)/%nmean (SD)/%nmean (SD)/%
Age424447.73 (16.30)350546.73 (16.52)73952.48 (14.34)
LA (mm)407543.1 (7.20)335542.12 (6.80)72047.69 (7.26)
MWT (mm)420019.47 (5.23)346119.33 (5.27)73920.14 (5.02)
FS %38620.41 (0.09)31740.41 (0.09)6880.41 (0.10)
LVOT max363432.67 (41.49)297531.11 (40.40)65939.75 (45.43)
Female15043512143529039
NYHA II13653410573130843
NYHA III, IV3779269810815
Hypertension1171289142725736
Diabetes22561686579
Vascular disease662412254
  • AF, atrial fibrillation; FS, fractional shortening; LA, left atrial; LVOT max, maximum left ventricular outflow gradient; MWT, maximal wall thickness; NYHA, New York Heart Association Functional Classification; SR, sinus rhythm.